Cite
Cost‐effectiveness of the McGill interactive pediatric oncogenetic guidelines in identifying Li–Fraumeni syndrome in female patients with osteosarcoma.
MLA
Rios, Juan David, et al. “Cost‐effectiveness of the McGill Interactive Pediatric Oncogenetic Guidelines in Identifying Li–Fraumeni Syndrome in Female Patients with Osteosarcoma.” Pediatric Blood & Cancer, vol. 71, no. 8, Aug. 2024, pp. 1–10. EBSCOhost, https://doi.org/10.1002/pbc.31077.
APA
Rios, J. D., Simbulan, F., Reichman, L., Caswell, K., Tachdjian, M., Malkin, D., Cotton, C., Nathan, P. C., Goudie, C., & Pechlivanoglou, P. (2024). Cost‐effectiveness of the McGill interactive pediatric oncogenetic guidelines in identifying Li–Fraumeni syndrome in female patients with osteosarcoma. Pediatric Blood & Cancer, 71(8), 1–10. https://doi.org/10.1002/pbc.31077
Chicago
Rios, Juan David, Frances Simbulan, Lara Reichman, Kimberly Caswell, Melissa Tachdjian, David Malkin, Cecilia Cotton, Paul C. Nathan, Catherine Goudie, and Petros Pechlivanoglou. 2024. “Cost‐effectiveness of the McGill Interactive Pediatric Oncogenetic Guidelines in Identifying Li–Fraumeni Syndrome in Female Patients with Osteosarcoma.” Pediatric Blood & Cancer 71 (8): 1–10. doi:10.1002/pbc.31077.